Contrary to these findings, IGFBP5 was found to inhibit growth of breast cancer cells in vitro and in vivo [48] and IGFBP5 overexpression was associated with improved breast cancer patient outcome in another study [63]. The gene discussed is IGFBP5; the disease is breast carcinoma.